Ligand Pharmaceuticals Inc (LGND)
73.90
+1.47
(+2.03%)
USD |
NASDAQ |
May 03, 16:00
73.90
0.00 (0.00%)
After-Hours: 18:44
Ligand Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 76.79M |
December 31, 2022 | 76.70M |
September 30, 2022 | 76.60M |
June 30, 2022 | 114.97M |
March 31, 2022 | 176.54M |
December 31, 2021 | 320.72M |
September 30, 2021 | 316.89M |
June 30, 2021 | 315.32M |
March 31, 2021 | 352.31M |
December 31, 2020 | 442.29M |
September 30, 2020 | 454.97M |
June 30, 2020 | 449.67M |
March 31, 2020 | 444.43M |
December 31, 2019 | 638.96M |
September 30, 2019 | 631.53M |
June 30, 2019 | 651.30M |
March 31, 2019 | 643.74M |
December 31, 2018 | 636.30M |
September 30, 2018 | 815.98M |
June 30, 2018 | 806.28M |
March 31, 2018 | 227.55M |
December 31, 2017 | 224.53M |
Date | Value |
---|---|
September 30, 2017 | 221.56M |
June 30, 2017 | 218.63M |
March 31, 2017 | 215.75M |
December 31, 2016 | 212.91M |
September 30, 2016 | 210.12M |
June 30, 2016 | 207.36M |
March 31, 2016 | 204.65M |
December 31, 2015 | 201.98M |
September 30, 2015 | 202.95M |
June 30, 2015 | 200.57M |
March 31, 2015 | 198.57M |
December 31, 2014 | 195.91M |
September 30, 2014 | 193.97M |
June 30, 2014 | 2.698M |
March 31, 2014 | 5.769M |
December 31, 2013 | 9.109M |
September 30, 2013 | 12.38M |
June 30, 2013 | 15.57M |
March 31, 2013 | 18.71M |
December 31, 2012 | 28.28M |
September 30, 2012 | 28.15M |
June 30, 2012 | 44.27M |
March 31, 2012 | 29.37M |
December 31, 2011 | 30.29M |
September 30, 2011 | 58.85M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2023
651.30M
Maximum
Jun 2019
291.58M
Average
316.89M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 285.67M |
ADMA Biologics Inc | 130.59M |
Viking Therapeutics Inc | -- |
Corcept Therapeutics Inc | 0.00 |
Palatin Technologies Inc | 0.00 |